Severe eosinophilia associated with hydroxychloroquine use in a patient with COVID-19

Impact Factor 2021: 3.041 (@Clarivate Analytics)

5-Year Impact Factor: 2.776 (@Clarivate Analytics)

Immediacy Index: 0.927

Impact Factor Rank: 10/24, Q2 (Tropical Medicine)

LETTER TO EDITOR

Year : 2021 \| Volume : 14 \| Issue : 6 \| Page : 285-286

Severe eosinophilia associated with hydroxychloroquine use in a patient with COVID-19 Resat Ozaras¹, Altan Bayar², Niiar Alioglu³, Semiha Baysoy⁴ ¹ Infectious Diseases Department, Medilife Hospital, TR-34524 Beylikdüzü, Istanbul, Turkey ² Intensive Care Unit, Medilife Hospital, TR-34200 Bagcilar, Istanbul, Turkey ³ Internal Medicine Department, Medilife Hospital, TR-34200 Bagcilar, Istanbul, Turkey ⁴ Pediatrics Department, Medilife Hospital, TR-34200 Bagcilar, Istanbul, Turkey Correspondence Address: Resat Ozaras Infectious Diseases Department, Medilife Hospital, TR-34524 Beylikdüzü, Istanbul Turkey Source of Support: None, Conflict of Interest: None DOI: 10.4103/1995-7645.314112





[FULL TEXT] [PDF]*

Table of Contents

Search Pubmed for

Search in Google Scholar for

Citation Manager

Access Statistics

Reader Comments

Email Alert *

Add to My List *

* Requires registration (Free)